You searched for - Page 179 of 429 - Institute for Bioengineering of Catalonia

June 23, 2020June 23, 2020

Artificial Intelligence tools to advance in the research and development of biomaterials

Experts in bioengineering and informatics, including IBEC´s Associated Researcher Maria-Pau Ginebra, have published a paper where the researchers propose the creation of tools based on Artificial Intelligence for the development of biomaterials in Nature Reviews Materials.

Nature Reviews Materials journal has published an article signed by scientists from the Barcelona Supercomputing Center (BSC), the Universitat Politècnica de Catalunya (UPC) and the Institute for Bioengineering of Catalonia (IBEC) outlining the great possibilities that artificial intelligence offers towards the progress in the design and development of biomaterials.

June 23, 2020

Mònica Mir explains how IBEC technology can help transplant patients’ quality of life

Dr. Mònica Mir, researcher at the Nanobioengineering Group at IBEC and leader of the Caixa Impulse funded project ISCHEMSURG, explained on World Transplant Day how this electrochemical sensor can monitor ischemia in transplanted tissue thus, improving transplant patients’ quality of life.

How did the ISCHEMSURG project take shape?

The project was born after speaking with medical doctors who told us about the problems they were having monitoring postoperative ischemia—an inadequate supply of blood—in transplanted tissue.

July 8, 2020June 20, 2020

Nuria Montserrat talks in the media about Mini-kidneys, diabetes and coronavirus

Researchers at the Institute of Bioengineering of Catalonia (IBEC) led by Núria Montserrat have found in vitro that diabetes is a disease that accelerates Covid-19. In the lab, they have also created mini-hearts to study the heart problems caused by Covid-19.

June 19, 2020June 19, 2020

Bioengineering against the most resistant and deadly bacterial infections

An international team, led by Profs Giuseppe Battaglia and Loris Rizzello from the Institute for Bioengineering of Catalonia (IBEC), carried out out a study that opens the door to a new therapy capable of quickly and effectively eliminating infections caused by intracellular bacteria, the most resistant to immune defenses.

This therapy, based on synthetic vesicles, could considerably reduce the dose and duration of antimicrobial treatments, thus reducing the danger of generating resistance to antibiotics of pathogens such as those leading to tuberculosis.

June 19, 2020

Nuria Montserrat presents to the Minister of Science and Innovation her project to fight coronavirus using bioengineered organoids

Nuria Montserrat, Group Leader at IBEC and ICREA Research Professor, meets with the Minister of Science and Innovation, Pedro Duque, to present her ACE2-ORG project, which seeks, by using organoids generated from bioengineering techniques, possible therapeutic solutions against the SARS-CoV-2 virus.

The Minister of Science and Innovation held a videoconference meeting this Thursday, June 18, with the responsibles of five research projects that are working on the development of new technologies to deal with SARS-CoV-2 and which are being financed by the Fund COVID-19, managed by the Carlos III Health Institute (ISCIII).

June 30, 2020June 19, 2020

A “faster and safer” therapy against tuberculosis

A team of international scientists led by the Institute for Bioengineering of Catalonia (IBEC) has developed a “faster, more effective and safer” therapy to eliminate infections of intracellular bacteria that cause diseases such as tuberculosis. Scientists participating in the study include Group Leader Giuseppe Battaglia and the researcher Loris Rizzello of IBEC.

June 18, 2020June 17, 2020

Josep Samitier talks about how the redistribution of funds will affect research

Josep Samitier, director of the Institute for Bioengineering of Catalonia and president of the Catalan Association of Research Entities (ACER), assesses how science and technology can be affected by the fact that 53 million euros, that had to be invested in research, have been redirected to the healthcare sector, due to the coronavirus outbreak.

June 18, 2020June 17, 2020

Artificial systems imitate how cells move and communicate

A review published in the scientific journal Small elegantly summarises the most important cellular biomimicry research of the past few years on synthetic soft-architectures, with a view to inspiring future developments in the field.

Samuel Sánchez, Group Leader at the Institute for Bioengineering of Catalonia (IBEC) co-authored this piece, alongside world-renowned experts in bioengineering and cell synthesis.

November 6, 2020June 11, 2020

Senior researcher at the Bioengineering in Reproductive Health Research Group

Application Deadline: 15/07/2020
Ref: SR-SO

The Bioengineering in reproductive health group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Senior Scientist to develop a project in collaboration with the industry.

The project involves investigate the molecular mechanisms affected by specific chemical treatments on endometrial receptivity and on mouse and human embryos in culture. We aim to combine the expertise in microscopy of the lab with embryology tools to understand the morphological and molecular modifications that lead to an increase in endometrial receptivity. An ideal candidate will have experience in the mouse or human embryology field and will know basic tools of molecular biology. The candidate will have a great degree of independence to coordinate the project, competitive salary and funding to outsource several tests (i.e. sequencing, histology etc.).

Our laboratory is a multidisciplinary environment where biologists, biophysicists, clinicians and business developers synergize to create a unique environment shaped by science and entrepreneurship. Due to the high translational component of our research, we have established collaboration contracts with the pharma industry, hospitals and venture capital to bring our technology to the clinics and the market.

In our lab we use bioengineering methods to create 3D environments that support embryonic development outside of the mother uterus. Our systems are accessible to imaging tools which allow us to interrogate the genetics, metabolomics and mechanics of the embryo in a high throughput manner. Using our systems we are capable to (i) improve embryo culture conditions and (ii) diagnose embryos with improved implantation potential.

June 10, 2020

IBEC committed with the creative talent of the future

The Institute for Bioengineering of Catalonia (IBEC) is the first research center to take part in the “Creative talent and Business” initiative launched by the Catalan Government.

Bioengineering involves addressing, understanding and solving highly complex problems in biomedicine. Research in nanomedicine, cell and tissue engineering, and new technologies for health will greatly change the way we face medical challenges.